A comparison of zopiclone and propiomazine as hypnotics in outpatients: A multicentre, double-blind, randomized, parallel-group comparison of zopiclone and propiomazine in insomniacs

References

• Almqvist M., Liljenberg B., Hetta J., Rimon R., Hambert G., Roos B.-E. Effects of propiomazine on the EEG sleep of normal subjects. Pharm. Tox. 1987; 61: 278, 2811. Almqvist M., Liljenberg B., Hetta J., Rimon R., Hambert G., Roos B.-E. Effects of propiomazine on the EEG sleep of normal subjects. Pharm. Tox. 1987; 61: 278, 281
   PubMedGoogle Scholar
• Bliwise D. L. Sleep in normal aging and dementia. Sleep 1993; 16: 46, 812. Bliwise D. L. Sleep in normal aging and dementia. Sleep 1993; 16: 46, 81
   Google Scholar
• Gaillot J., Le Roux Y., Houghton G. W., Dreyfus J. F. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency. Sleep 1987; 10: 7–21, (Suppl 1)3. Gaillot J., Le Roux Y., Houghton G. W., Dreyfus J. F. Critical factors for pharmacokinetics of zopiclone in the elderly and in patients with liver and renal insufficiency. Sleep 1987; 10: 7–21, (Suppl 1)
   PubMed Web of Science ®Google Scholar
• Goa K. L., Heel R. C. Zopiclone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 1991; 32: 48, 65, Updated version, June, 19914. Goa K. L., Heel R. C. Zopiclone: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 1991; 32: 48, 65, Updated version, June, 1991
   Google Scholar
• Good Clinical Trial Practice: Nordic Guidelines. Nordiska läkemedelsnämnden. 1989, Uppsala, NLN Publication No. 285. Good Clinical Trial Practice: Nordic Guidelines. Nordiska läkemedelsnämnden. 1989, Uppsala, NLN Publication No. 28
   Google Scholar
• Hartvig P., Roos B.-E., Åhs U., Ryde M. Pharmacokinetics of propio-mazine following intravenous, intramuscular and oral administration with special reference to the elimination phase. Curr. Ther., Res. 1981; 29: 351, 3626. Hartvig P., Roos B.-E., Åhs U., Ryde M. Pharmacokinetics of propio-mazine following intravenous, intramuscular and oral administration with special reference to the elimination phase. Curr. Ther., Res. 1981; 29: 351, 362
   Web of Science ®Google Scholar
• Hindmarch I. Zopiclone monograph. ADIS Press International Ltd, Manchester 19907. Hindmarch I. Zopiclone monograph. ADIS Press International Ltd, Manchester 1990
   Google Scholar
• Lader M. Rebound insomnia and newer hypnotics. Psychopharmacol. 1992; 108: 248, 2558. Lader M. Rebound insomnia and newer hypnotics. Psychopharmacol. 1992; 108: 248, 255
   PubMed Web of Science ®Google Scholar
• Nicholson A. N., Bradley C. M., Pascoe P. A. Medications: effect on sleep and wakefulness. Principles and Proctice of Sleep Medicine, M. H. Kryger, T. Roth, W. C. Dement. W. B. Saunders, Philadelphia 19899. Nicholson A. N., Bradley C. M., Pascoe P. A. Medications: effect on sleep and wakefulness. Principles and Proctice of Sleep Medicine, M. H. Kryger, T. Roth, W. C. Dement. W. B. Saunders, Philadelphia 1989
   Google Scholar
• Risinger C. Prövning av propiomazin-inlägg i sömnmedelsdebatten. Läkortidmngen 1980; 77: 39, 9710. Risinger C. Prövning av propiomazin-inlägg i sömnmedelsdebatten. Läkortidmngen 1980; 77: 39, 97
   PubMedGoogle Scholar
• Roslund K., Olsen I. A clinical trial of propiomazine and placebo in the treatment of insomnia in the elderly. Curr. Ther. Res. 1987; 4: 6, 1211. Roslund K., Olsen I. A clinical trial of propiomazine and placebo in the treatment of insomnia in the elderly. Curr. Ther. Res. 1987; 4: 6, 12
   Google Scholar
• Skoog I., Nilsson L., Landahl S., Steen B. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int. Psychogeriat. 1993; 5: 33, 4812. Skoog I., Nilsson L., Landahl S., Steen B. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int. Psychogeriat. 1993; 5: 33, 48
   PubMedGoogle Scholar
• Wadworth A. N., McTavish D. Zopiclone: A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs Aging 1993; 3: 441, 45913. Wadworth A. N., McTavish D. Zopiclone: A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs Aging 1993; 3: 441, 459
   PubMed Web of Science ®Google Scholar
• Viukari M., Miettinen P. Diazepam, promethazine and propiomazine as hypnotics in elderly inpatients. Neuropsychobiol. 1954; 12: 134, 13714. Viukari M., Miettinen P. Diazepam, promethazine and propiomazine as hypnotics in elderly inpatients. Neuropsychobiol. 1954; 12: 134, 137
   Google Scholar